Washington, DC (PRWEB) November 9, 2007 -- www.shire.com [Shire plc] (LSE: SHP, NASDAQ: SHPGY, TSX: SHQ), the global specialty biopharmaceutical company, yesterday announced results of a national...
Posted by Vyvanse In the News on at
Filed under Vyvanse News · Tagged with Adhd, Adhd Medication, Duration, Lse, Medical Meeting, Medication, Nasdaq, Parents, Perceptions, Prweb, Shp, Shpgy, Survey, Tsx, Washington Dc
Boston (PRWEB) October 29, 2007 -- Shire plc (LSE: SHP, NASDAQ: SHPGY, TSX: SHQ), the global specialty biopharmaceutical company, today announced the results of a study which demonstrated that adults...
Posted by Vyvanse In the News on at
Filed under Vyvanse News · Tagged with Adhd, Adult Adhd, Adults, Boston, Lisdexamfetamine Dimesylate, Lse, Nasdaq, Pivotal Trial, Prweb, Shp, Shpgy, Tsx
Boston (PRWEB) October 29, 2007 -- Shire plc (LSE: SHP, NASDAQ: SHPGY, TSX: SHQ), the global specialty biopharmaceutical company, today announced results from an analysis of VYVANSE™...
Boston (PRWEB) October 29, 2007 -- Shire plc (LSE: SHP, NASDAQ: SHPGY, TSX: SHQ), the global specialty biopharmaceutical company, announced that data from a 12-month www.daytrana.com [study] of...
Posted by Vyvanse In the News on at
Filed under Vyvanse News · Tagged with Adhd, Boston, Company Announced That, Lse, Methylphenidate, Nasdaq, Prweb, Safety Data, Shp, Shpgy, Tsx
